Daniel M. Bradbury has been named president and chief executive officer, Amylin Pharmaceuticals, Inc., effective March 1, 2007. He will succeed Ginger L. Graham, who has led the company since 2003. In June 2006, Mr. Bradbury was named president and chief operating officer and became a member of the board of directors. He previously served as executive vice president from June 2000 until his promotion to chief operating officer in June 2003. He joined the company in 1994 and has held officer...